Six Companies Chosen to Supply Products To France’s First Medical Cannabis Trial - 26/01/2021


Six companies have seen their products selected for use in the French medical cannabis trial for 3,000 patients which is set to begin within weeks.


Leading French cannabis consultant Benjamin-Alexandre Jeanroy Co-Founder & CEO of Augur Associates welcomed the news: “Although the French experiment integrates only a fraction of the patients in need, it’s pleasing to see the process finally start with the first prescriptions set to begin by the end of March. Bravo to the everyone involved for their work and to the ANSM for their efforts in the midst of the current health crisis.”


Click here to read more on Business Cann

Paris

© AUGUR.ASSOCIATES

Création Enanti.fr    Mentions légales

  • Instagram
  • Facebook
  • Twitter